Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Expression of IFNAR2 mRNA in peripheral blood mononuclear cells of patients with HCV infection.

Liu N, Wen Y, Sun C, Liu P.

Acta Gastroenterol Belg. 2012 Jun;75(2):228-33.

PMID:
22870788
2.

Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study.

Fujiwara D, Hino K, Yamaguchi Y, Kubo Y, Yamashita S, Uchida K, Konishi T, Nakamura H, Korenaga M, Okuda M, Okita K.

J Viral Hepat. 2004 Mar;11(2):136-40.

PMID:
14996348
3.
4.

Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.

Massirer KB, Hirata MH, Silva AE, Ferraz ML, Nguyen NY, Hirata RD.

Braz J Med Biol Res. 2004 May;37(5):643-7. Epub 2004 Apr 22.

5.

Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.

Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J.

Jpn J Infect Dis. 2007 Feb;60(1):29-32.

7.

Expression of microRNA-155 precursor in peripheral blood mononuclear cells from Hepatitis C patients after antiviral treatment.

Sidorkiewicz M, Grek M, Jozwiak B, Majda-Stanislawska E, Piekarska A, Bartkowiak J.

Acta Virol. 2010;54(1):75-8.

PMID:
20201617
8.

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.

Pugnale P, Herrmann E, Neumann AU, Pawlotsky JM, Schalm SW, Ferrari C, Homburger Y, Zeuzem S, Negro F; DITTO-HCV Study Group.

J Hepatol. 2008 Jun;48(6):932-8. doi: 10.1016/j.jhep.2008.02.018. Epub 2008 Mar 31.

PMID:
18433918
9.

Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.

Morita K, Tanaka K, Saito S, Kitamura T, Kondo M, Sakaguchi T, Morimoto M, Sekihara H.

J Clin Gastroenterol. 1998 Mar;26(2):135-40.

PMID:
9563926
10.

Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.

Inglot M, Pawlowski T, Szymczak A, Malyszczak K, Zalewska M, Radkowski M.

Postepy Hig Med Dosw (Online). 2013 Mar 11;67:186-91.

11.

Sustained virological response: a milestone in the treatment of chronic hepatitis C.

Morisco F, Granata R, Stroffolini T, Guarino M, Donnarumma L, Gaeta L, Loperto I, Gentile I, Auriemma F, Caporaso N.

World J Gastroenterol. 2013 May 14;19(18):2793-8. doi: 10.3748/wjg.v19.i18.2793.

12.

Presence of HCV RNA in peripheral blood mononuclear cells may predict patients response to interferon and ribavirin therapy.

Zaman N, Asad MJ, Raza A, Raja GK, Akhter S, Mahmood M, Mahmood RT.

Ann Saudi Med. 2014 Sep-Oct;34(5):401-6. doi: 10.5144/0256-4947.2014.401.

13.

[Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].

Fan HB, Guo YB, Wang BJ, Zhu YF, Wu AH, Hou JL, Yang DL.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Jun;28(6):979-81. Chinese.

14.

Hepatic interferon receptor mRNA expression: clinical relevance and its relationship with effectiveness of interferon plus ribavirin therapy in patients with genotype 1b hepatitis C virus infection.

Lee CM, Kee KM, Hung CH, Eng HL, Chang CH, Huang CM, Wang JH, Hu TH, Lu SN, Changchien CS, Chen WJ.

Antivir Ther. 2006;11(1):17-23.

PMID:
16518956
15.

Associations between human TRIM22 gene expression and the response to combination therapy with Peg-IFNα-2a and ribavirin in Iranian patients with chronic hepatitis C.

Sadeghi F, Bokharaei-Salim F, Salehi-Vaziri M, Monavari SH, Alavian SM, Salimi S, Vahabpour R, Keyvani H.

J Med Virol. 2014 Sep;86(9):1499-506. doi: 10.1002/jmv.23985. Epub 2014 May 29.

PMID:
24889558
16.

Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.

Kessler HH, Pierer K, Santner BI, Vellimedu SK, Stelzl E, Marth E, Fickert P, Stauber RE.

J Hum Virol. 1998 Jul-Aug;1(5):314-9.

PMID:
10195258
17.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
18.

Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.

Majda-Stanisławska E, Bednarek M, Jóźwiak B, Sidorkiewicz M, Piekarska A, Kuydowicz J.

Acta Gastroenterol Belg. 2006 Apr-Jun;69(2):187-90.

PMID:
16929613
19.

Expression of interferon-alpha receptor mRNA in the liver in chronic liver diseases associated with hepatitis C virus: relation to effectiveness of interferon therapy.

Fukuda R, Ishimura N, Ishihara S, Tokuda A, Satoh S, Sakai S, Akagi S, Watanabe M, Fukumoto S.

J Gastroenterol. 1996 Dec;31(6):806-11.

PMID:
9027643
20.

Influence of genes suppressing interferon effects in peripheral blood mononuclear cells during triple antiviral therapy for chronic hepatitis C.

Iijima S, Matsuura K, Watanabe T, Onomoto K, Fujita T, Ito K, Iio E, Miyaki T, Fujiwara K, Shinkai N, Kusakabe A, Endo M, Nojiri S, Joh T, Tanaka Y.

PLoS One. 2015 Feb 23;10(2):e0118000. doi: 10.1371/journal.pone.0118000. eCollection 2015.

Supplemental Content

Support Center